(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 7.13%3.87B | -15.12%7.08B | -14.66%3.61B | 6.31%8.34B | --4.23B | 23.28%7.84B | 84.32%6.36B | 198.45%3.45B | --1.16B |
Operating income | 7.13%3.87B | -15.12%7.08B | -14.66%3.61B | 6.31%8.34B | 4.23B | 23.28%7.84B | 84.32%6.36B | 198.45%3.45B | 1.16B |
Cost of sales | -7.42%-3.72B | 16.34%-6.79B | 13.84%-3.46B | -9.50%-8.12B | ---4.02B | -22.81%-7.41B | -87.92%-6.04B | -205.98%-3.21B | ---1.05B |
Operating expenses | -7.42%-3.72B | 16.34%-6.79B | 13.84%-3.46B | -9.50%-8.12B | -4.02B | -22.81%-7.41B | -87.92%-6.04B | -205.98%-3.21B | -1.05B |
Gross profit | 0.25%150.82M | 30.11%286.02M | -29.98%150.45M | -48.80%219.83M | 214.88M | 31.96%429.37M | 36.00%325.38M | 124.33%239.26M | 106.66M |
Selling expenses | -52.41%-16.07M | -23.96%-30.56M | 9.80%-10.54M | 10.45%-24.66M | ---11.69M | -46.47%-27.53M | -2.95%-18.8M | -34.38%-18.26M | ---13.59M |
Administrative expenses | -19.65%-41.87M | 9.69%-74.05M | -0.25%-35M | -25.43%-81.99M | ---34.91M | -46.30%-65.37M | -57.27%-44.68M | -46.32%-28.41M | ---19.42M |
Research and development expenses | 2.62%-4.43M | 49.64%-8.82M | 60.74%-4.55M | -27.52%-17.51M | ---11.58M | -212.07%-13.73M | ---4.4M | ---- | ---- |
Impairment and provision | 4.28%-30.91M | -113.03%-45.91M | -608.02%-32.29M | 24.23%-21.55M | ---4.56M | 47.08%-28.44M | 30.65%-53.74M | -8,268.57%-77.49M | ---926K |
-Other impairment is provision | 4.28%-30.91M | -113.03%-45.91M | -608.02%-32.29M | 24.23%-21.55M | ---4.56M | 47.08%-28.44M | 30.65%-53.74M | -8,268.57%-77.49M | ---926K |
Special items of operating profit | -2.96%-7.51M | -101.32%-1.2M | -212.12%-7.3M | 44.76%90.65M | --6.51M | 3,255.89%62.62M | -70.09%1.87M | 1,886.62%6.24M | --314K |
Operating profit | -17.69%50.02M | -23.85%125.48M | -61.69%60.77M | -53.83%164.78M | 158.65M | 73.58%356.92M | 69.47%205.63M | 66.12%121.33M | 73.04M |
Financing income | 159.98%10.14M | 134.12%12.52M | 14.16%3.9M | 225.56%5.35M | --3.42M | 544.31%1.64M | -2.67%255K | 18.02%262K | --222K |
Financing cost | 38.57%-8.27M | 2.78%-20.78M | -29.49%-13.47M | 17.94%-21.38M | ---10.4M | 5.90%-26.05M | -143.01%-27.69M | -161.49%-11.39M | ---4.36M |
Earning before tax | 1.34%51.89M | -21.19%117.22M | -66.24%51.21M | -55.27%148.75M | 151.66M | 86.60%332.51M | 61.70%178.2M | 59.94%110.2M | 68.9M |
Tax | 6.43%-8.74M | 25.36%-26.25M | 70.56%-9.34M | 55.01%-35.17M | ---31.72M | -73.62%-78.16M | -59.15%-45.02M | -50.79%-28.29M | ---18.76M |
After-tax profit from continuing operations | 3.07%43.15M | -19.90%90.97M | -65.09%41.87M | -55.35%113.58M | 119.95M | 90.98%254.35M | 62.58%133.18M | 63.36%81.91M | 50.14M |
Earning after tax | 3.07%43.15M | -19.90%90.97M | -65.09%41.87M | -55.35%113.58M | 119.95M | 90.98%254.35M | 62.58%133.18M | 63.36%81.91M | 50.14M |
Minority profit | ---261K | --412K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 3.69%43.41M | -20.27%90.56M | -65.09%41.87M | -55.35%113.58M | 119.95M | 90.98%254.35M | 62.58%133.18M | 63.36%81.91M | 50.14M |
Basic earnings per share | 0.00%0.07 | -21.05%0.15 | -65.00%0.07 | -63.46%0.19 | 0.2 | 67.74%0.52 | -99.32%0.31 | 63.35%45.51 | 27.86 |
Diluted earnings per share | 0.00%0.07 | -21.05%0.15 | -65.00%0.07 | -63.46%0.19 | 0.2 | 67.74%0.52 | -99.32%0.31 | 63.35%45.51 | 27.86 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data